TY - JOUR AU - Goodman, W. G. AU - London, G. AU - Amann, K. AU - Block, G. A. AU - Giachelli, C. AU - Hruska, K. A. PY - 2011 DA - 2011// TI - Vascular Calcification Work Group: Vascular calcification in chronic kidney disease JO - Am J Kidney Dis. VL - 43 UR - https://doi.org/10.1053/j.ajkd.2003.12.005 DO - 10.1053/j.ajkd.2003.12.005 ID - Goodman2011 ER - TY - JOUR AU - Block, G. A. AU - Hulbert-Shearon, T. E. AU - Levin, N. W. AU - Port, F. K. PY - 1998 DA - 1998// TI - Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study JO - Am J Kidney Dis VL - 31 UR - https://doi.org/10.1053/ajkd.1998.v31.pm9531176 DO - 10.1053/ajkd.1998.v31.pm9531176 ID - Block1998 ER - TY - JOUR AU - Hruska, K. A. AU - Mathew, S. AU - Lund, R. AU - Qiu, P. AU - Pratt, R. PY - 2008 DA - 2008// TI - Hyperphosphatemia of chronic kidney disease JO - Kidney Int. VL - 74 UR - https://doi.org/10.1038/ki.2008.130 DO - 10.1038/ki.2008.130 ID - Hruska2008 ER - TY - JOUR AU - Scialla, J. J. AU - Kao, W. H. AU - Crainiceanu, C. AU - Sozio, S. M. AU - Oberai, P. C. AU - Shafi, T. PY - 2014 DA - 2014// TI - Biomarkers of vascular calcification and mortality in patients with ESRD JO - Clin J Am Soc Nephrol. VL - 9 UR - https://doi.org/10.2215/CJN.05450513 DO - 10.2215/CJN.05450513 ID - Scialla2014 ER - TY - JOUR AU - Liabeuf, S. AU - Okazaki, H. AU - Desjardins, L. AU - Fliser, D. AU - Goldsmith, D. AU - Covic, A. PY - 2014 DA - 2014// TI - Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? JO - Nephrol Dial Transplant. VL - 29 UR - https://doi.org/10.1093/ndt/gft368 DO - 10.1093/ndt/gft368 ID - Liabeuf2014 ER - TY - JOUR AU - Ketteler, M. AU - Bongartz, P. AU - Westenfeld, R. AU - Wildberger, J. E. AU - Mahnken, A. H. AU - Böhm, R. PY - 2003 DA - 2003// TI - Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study JO - Lancet. VL - 361 UR - https://doi.org/10.1016/S0140-6736(03)12710-9 DO - 10.1016/S0140-6736(03)12710-9 ID - Ketteler2003 ER - TY - JOUR AU - Jung, H. H. AU - Baek, H. J. AU - Kim, S. W. PY - 2011 DA - 2011// TI - Fetuin-A, coronary artery calcification and outcome in maintenance hemodialysis patients JO - Clin Nephrol VL - 75 UR - https://doi.org/10.5414/CNP75391 DO - 10.5414/CNP75391 ID - Jung2011 ER - TY - JOUR AU - Jahnen-Dechent, W. AU - Schäfer, C. AU - Heiss, A. AU - Grötzinger, J. PY - 2001 DA - 2001// TI - Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin JO - Z Kardiol VL - 90 ID - Jahnen-Dechent2001 ER - TY - JOUR AU - Gangneux, C. AU - Daveau, M. AU - Hiron, M. AU - Derambure, C. AU - Papaconstantinou, J. AU - Salier, J. P. PY - 2003 DA - 2003// TI - The inflammation-induced downregulation of plasma Fetuin-A (alpha2HS- glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites JO - Nucleic Acids Res VL - 31 UR - https://doi.org/10.1093/nar/gkg788 DO - 10.1093/nar/gkg788 ID - Gangneux2003 ER - TY - JOUR AU - Brylka, L. AU - Jahnen-Dechent, W. PY - 2013 DA - 2013// TI - The role of fetuin-A in physiological and pathological mineralization JO - Calcif Tissue Int VL - 93 UR - https://doi.org/10.1007/s00223-012-9690-6 DO - 10.1007/s00223-012-9690-6 ID - Brylka2013 ER - TY - JOUR AU - Jahnen-Dechent, W. AU - Heiss, A. AU - Schafer, C. AU - Ketteler, M. PY - 2011 DA - 2011// TI - Fetuin- A regulation of calcified matrix metabolism JO - Circ Res. VL - 108 UR - https://doi.org/10.1161/CIRCRESAHA.110.234260 DO - 10.1161/CIRCRESAHA.110.234260 ID - Jahnen-Dechent2011 ER - TY - JOUR AU - Chertow, G. M. AU - Burke, S. K. AU - Raggi, P. PY - 2002 DA - 2002// TI - Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients JO - Kidney Int VL - 62 UR - https://doi.org/10.1046/j.1523-1755.2002.00434.x DO - 10.1046/j.1523-1755.2002.00434.x ID - Chertow2002 ER - TY - JOUR AU - Raggi, P. AU - Vukicevic, S. AU - Moyses, R. M. AU - Wesseling, K. AU - Spiegel, D. M. PY - 2010 DA - 2010// TI - Ten-year experience with sevelamer and calcium salts as phosphate binders JO - Clin J Am Soc Nephrol VL - 5 UR - https://doi.org/10.2215/CJN.05880809 DO - 10.2215/CJN.05880809 ID - Raggi2010 ER - TY - JOUR AU - Iimori, S. AU - Mori, Y. AU - Akita, W. AU - Takada, S. AU - Kuyama, T. AU - Ohnishi, T. PY - 2012 DA - 2012// TI - Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study JO - Clin Exp Nephrol VL - 16 UR - https://doi.org/10.1007/s10157-012-0640-4 DO - 10.1007/s10157-012-0640-4 ID - Iimori2012 ER - TY - JOUR AU - Iorio, B. AU - Bellasi, A. AU - Russo, D. PY - 2012 DA - 2012// TI - Mortality in kidney disease patients treated with phosphate binders: a randomized study JO - Clin J Am Soc Nephrol VL - 7 UR - https://doi.org/10.2215/CJN.03820411 DO - 10.2215/CJN.03820411 ID - Iorio2012 ER - TY - JOUR AU - Slatopolsky, E. A. AU - Burke, S. K. AU - Dillon, M. A. PY - 1999 DA - 1999// TI - RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group JO - Kidney Int VL - 55 UR - https://doi.org/10.1046/j.1523-1755.1999.00240.x DO - 10.1046/j.1523-1755.1999.00240.x ID - Slatopolsky1999 ER - TY - JOUR AU - Nikolov, I. G. AU - Joki, N. AU - Maizel, J. AU - Lacour, B. AU - Drüeke, T. B. AU - Massy, Z. A. PY - 2006 DA - 2006// TI - Pleiotropic effects of the non-calcium phosphate binder sevelamer JO - Kidney Int. VL - 70 UR - https://doi.org/10.1038/sj.ki.5001994 DO - 10.1038/sj.ki.5001994 ID - Nikolov2006 ER - TY - JOUR AU - Rastogi, A. PY - 2013 DA - 2013// TI - Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease JO - Ther Adv Cardiovasc Dis VL - 7 UR - https://doi.org/10.1177/1753944713513061 DO - 10.1177/1753944713513061 ID - Rastogi2013 ER - TY - JOUR AU - Ikee, R. AU - Tsunoda, M. AU - Sasaki, N. AU - Sato, N. AU - Hashimoto, N. PY - 2013 DA - 2013// TI - Emerging effects of sevelamer in chronic kidney disease JO - Kidney Blood Press Res VL - 37 UR - https://doi.org/10.1159/000343397 DO - 10.1159/000343397 ID - Ikee2013 ER - TY - JOUR AU - Caglar, K. AU - Yilmaz, M. I. AU - Saglam, M. AU - Cakir, E. AU - Acikel, C. AU - Eyileten, T. PY - 2008 DA - 2008// TI - Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients JO - Clin J Am Soc Nephrol VL - 3 UR - https://doi.org/10.2215/CJN.02810707 DO - 10.2215/CJN.02810707 ID - Caglar2008 ER - TY - JOUR AU - Brandenburg, V. M. AU - Schlieper, G. AU - Heussen, N. AU - Holzmann, S. AU - Busch, B. AU - Evenepoel, P. PY - 2010 DA - 2010// TI - Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study JO - Nephrol Dial Transplant VL - 25 UR - https://doi.org/10.1093/ndt/gfq053 DO - 10.1093/ndt/gfq053 ID - Brandenburg2010 ER - TY - JOUR AU - Lin, H. H. AU - Liou, H. H. AU - Wu, M. S. AU - Lin, C. Y. AU - Huang, C. C. PY - 2014 DA - 2014// TI - Long-term sevelamer treatment lowers serum FGF23 accompanied with increasing serum KlothoLevels in chronic hemodialysis patients JO - Nephrology VL - 19 UR - https://doi.org/10.1111/nep.12319 DO - 10.1111/nep.12319 ID - Lin2014 ER - TY - JOUR AU - Schinke, T. AU - Amendt, C. AU - Trindl, A. AU - Pöschke, O. AU - Müller-Esterl, W. AU - Jahnen-Dechent, W. PY - 1996 DA - 1996// TI - The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis JO - J Biol Chem VL - 271 UR - https://doi.org/10.1074/jbc.271.34.20789 DO - 10.1074/jbc.271.34.20789 ID - Schinke1996 ER - TY - JOUR AU - Schafer, C. AU - Heiss, A. AU - Schwarz, A. AU - Westenfeld, R. AU - Ketteler, M. AU - Floege, J. PY - 2003 DA - 2003// TI - The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin- A is a systemically acting inhibitor of ectopic calcification JO - J Clin Invest. VL - 112 UR - https://doi.org/10.1172/JCI17202 DO - 10.1172/JCI17202 ID - Schafer2003 ER - TY - JOUR AU - Haddad, M. AU - Tajbakhsh, R. AU - Farajollahi, M. AU - Qorbani, M. AU - Besharat, S. AU - Joshaghani, H. R. PY - 2014 DA - 2014// TI - Association of serum fetuin-A and biochemical parameters in hemodialysis patients JO - Saudi J Kidney Dis Transpl VL - 25 UR - https://doi.org/10.4103/1319-2442.134993 DO - 10.4103/1319-2442.134993 ID - Haddad2014 ER - TY - JOUR AU - Jung, H. H. AU - Kim, S. W. AU - Han, H. PY - 2006 DA - 2006// TI - Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis JO - Nephrol Dial Transplant. VL - 21 UR - https://doi.org/10.1093/ndt/gfl118 DO - 10.1093/ndt/gfl118 ID - Jung2006 ER - TY - JOUR AU - Manenti, L. AU - Vaglio, A. AU - Pasquali, S. PY - 2010 DA - 2010// TI - Increased fetuin-A levels following treatment with a vitamin D analog JO - Kidney Int. VL - 78 UR - https://doi.org/10.1038/ki.2010.357 DO - 10.1038/ki.2010.357 ID - Manenti2010 ER - TY - JOUR AU - Massart, A. AU - Debelle, F. D. AU - Racapé, J. AU - Gervy, C. AU - Husson, C. AU - Dhaene, M. PY - 2014 DA - 2014// TI - Biochemical parameters after cholecalciferol repletion in hemodialysis: results from the VitaDial Randomized Trial JO - Am J Kidney Dis VL - 64 UR - https://doi.org/10.1053/j.ajkd.2014.04.020 DO - 10.1053/j.ajkd.2014.04.020 ID - Massart2014 ER -